Analysis of Jak2 signaling reveals resistance of mouse embryonic hematopoietic stem cells to myeloproliferative disease mutation. (2016)

First Author: Mascarenhas MI
Attributed to:  Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood-2015-08-664631

PubMed Identifier: 26864339

Publication URI: http://europepmc.org/abstract/MED/26864339

Type: Journal Article/Review

Volume: 127

Parent Publication: Blood

Issue: 19

ISSN: 0006-4971